Methyl 3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate: A Key Pharmaceutical Intermediate
Discover the critical role of this advanced chemical intermediate in the synthesis of life-saving targeted cancer therapies.
Get a Quote & SampleProduct Core Value
![Methyl 3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate](https://www.nbinno.com/webimg/gemini_68894f1819b51_1753829144.png)
Methyl 3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate
This compound serves as a vital building block in the pharmaceutical industry, particularly in the development of targeted therapies for cancer. Its precise chemical structure and high purity are essential for synthesizing complex active pharmaceutical ingredients (APIs) like Dabrafenib, a BRAF inhibitor used in melanoma treatment. Leveraging its unique properties, researchers can advance drug discovery and development, contributing to novel therapeutic solutions.
- High Purity Pharmaceutical Intermediate: This methyl ester of 3-[[(2,6-difluorophenyl)sulfonyl]amino]-2-fluorobenzoic acid ensures optimal results in complex organic synthesis pathways, critical for dabrafenib intermediate methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate production.
- Key for Targeted Cancer Therapies: Essential for the synthesis of BRAF inhibitors, contributing to advanced treatments for cancers like melanoma, making it a crucial component in pharmaceutical intermediate methyl 3-((2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate applications.
- Chemical Structure Significance: The presence of fluorine atoms and the sulfonylamino benzoate structure provide unique reactivity and properties valuable in 2,6-difluorophenyl sulfonyl amino benzoate methyl ester research and development.
- Reliable Synthesis Intermediate: With a purity of ≥98.0%, this compound supports consistent and high-yield outcomes in the synthesis of dabrafenib intermediate and related compounds.
Key Advantages for Your Research and Production
Enhanced Synthesis Yields
Utilizing high-purity intermediates like this methyl ester can significantly improve the efficiency and success rates in your drug synthesis processes, supporting the reliable dabrafenib intermediate methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate production.
Accelerated Drug Discovery
As a critical component in the development of targeted cancer therapies, this chemical accelerates research efforts in medicinal chemistry and drug discovery, particularly for compounds related to cas 1195768-19-4 intermediate applications.
Facilitates Complex Molecular Construction
The specific structural features of this fluorinated compound make it an ideal building block for constructing complex molecules needed for cutting-edge pharmaceutical research, such as those in the synthesis of dabrafenib intermediate.
Key Applications
Pharmaceutical Synthesis
Essential intermediate in the manufacturing of Active Pharmaceutical Ingredients (APIs), particularly for targeted cancer therapies like Dabrafenib, underscoring its role in pharmaceutical intermediate methyl 3-((2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate applications.
Medicinal Chemistry Research
A valuable compound for exploring new molecular entities and therapeutic pathways, aiding researchers in discovering novel treatments and understanding complex biological mechanisms related to dabrafenib intermediate methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate.
Oncology Drug Development
Crucial for the development of BRAF inhibitors and other anti-cancer agents, supporting advancements in the treatment of cancers like melanoma and contributing to the field of 2,6-difluorophenyl sulfonyl amino benzoate methyl ester research.
Fine Chemical Manufacturing
Supplied with high purity, this chemical is sought after by fine chemical manufacturers for its role in complex organic synthesis, including the production of cas 1195768-19-4 intermediate.